Intravenous immunoglobulin G in women with reproductive failure: The Korean Society for Reproductive Immunology practice guidelines.

Author: Nayoung SUNG ¹ ; Ae Ra HAN ; Chan Woo PARK ; Dong Wook PARK ; Joon Cheol PARK ; Na Young KIM ; Kyung Sil LIM ; Ji Eun SHIN ; Chang Woo JOO ; Seung Eun LEE ; Jae Won KIM ; Sung Ki LEE
Author Information

1. Department of Obstetrics and Gynecology, Pusan National University Yangsan Hospital, Yangsan, Korea.
Publication Type:Review
Keywords: Immunity; Intravenous immunoglobulin G; Natural killer cell; Recurrent miscarriage; Infertility
MeSH: Abortion, Habitual; Advisory Committees; Allergy and Immunology*; Female; Humans; Immunoglobulin G*; Immunoglobulins*; Immunologic Factors; Infertility; Killer Cells, Natural; Pregnancy
From:Clinical and Experimental Reproductive Medicine 2017;44(1):1-7
CountryRepublic of Korea
Language:English
Abstract: The task force of the Korean Society for Reproductive Immunology recommends intravenous immunoglobulin G treatment in women with reproductive failure, including recurrent pregnancy loss and/or repeated implantation failure, who show cellular immune factors such as abnormal natural killer cell levels, natural killer cell cytotoxicity, and/or type 1 T helper immunity.